Dishman Carbogen Amcis DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1.08×	0.93×	0.17×	1.26×	0.55×
	0.11×	0.46×	0.11×	5.02×	−1.06×
	4.7%	7.7%	6.5%	−0.9%	2.1%
	0.27×	0.27×	0.28×	0.27×	0.27×
	1.79×	1.79×	1.71×	1.70×	1.63×
	0.3%	1.6%	0.1%	−2.7%	−0.5%
	1.6%	1.6%	0.1%	−2.7%	−0.5%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DCAL₹136.00

Dishman Carbogen Amcis Limited

· Pharma & Health

₹ CrorePeersHIKAL SOLARA PANACEABIO INDSWFTLAB SAIPARENT INDOCO SMSPHARMA WINDLASMcap ₹2,132 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.55	1.26	0.17	0.93	1.08
Interest Burden (Pretax/EBIT) ×	-1.06	5.02	0.11	0.46	0.11
EBIT Margin %	2.13	-0.93	6.46	7.74	4.72
Asset Turnover ×	0.27	0.27	0.28	0.27	0.27
Financial Leverage (Assets/Equity) ×	1.63	1.70	1.71	1.79	1.79
ROE (5-step product, year-end total equity) %	-0.54	-2.70	0.06	1.60	0.27
ROE (owners' profit / average owners' equity) %	-0.52	-2.68	0.06	1.56	1.56

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.